1. Field of the Invention
Implementations described herein relate generally to surgical devices and relate more specifically to temporary embolic protection devices and associated methods.
2. Related Art
Deep vein thrombosis (DVT) can be described as the formation of a blood clot or thrombus in a deep vein, predominately in the legs. Similarly, subclavian vein and axillary vein thrombosis (ASVT) are described as the formation of a blood clot or thrombosis in the subclavian vein or axillary veins between the clavicle and ribs. Pulmonary embolism is caused by the detachment or embolism of a clot that travels to the lungs. Together, DVT, ASVT and pulmonary embolism constitute a single disease process known as venous thromboembolism. Thrombectomy is a procedure used to break up clots and can be a percutaneous, catheter-based procedure. Percutaneous thrombectomy devices can be categorized as rotational, rheolytic or ultrasound enhanced. No matter the operational modality, distal embolism is a risk inherent to thrombectomy. Accordingly, a need exists for improved temporary embolic protection devices and associated methods.
It is to be understood that this summary is not an extensive overview of the disclosure. This summary is exemplary and not restrictive, and it is intended to neither identify key or critical elements of the disclosure nor delineate the scope thereof. The sole purpose of this summary is to explain and exemplify certain concepts of the disclosure as an introduction to the following complete and extensive detailed description.
Stated generally, the present disclosure comprises a percutaneous transluminal temporary embolic filter and is intended for use as an adjunct to medical procedures where distal embolization is a risk.
Stated more specifically, the present disclosure comprises a catheter having an elongated shaft, proximal and distal ends, a longitudinal axis and a filter. The filter comprises a first ring coaxially fixedly mounted on a distal portion of the catheter shaft, a second ring coaxially slidably mounted on a distal portion of the catheter shaft and configured to be moved toward and away from the first ring and a scaffolding extending between the first and second rings. The scaffolding further comprises a plurality of first longitudinal connecting members, each having a first end attached to the first ring and a second end extending toward the second ring; a plurality of second longitudinal connecting members, each having a first end attached to the second ring and a second end extending toward the first ring. The filter further comprises a membrane connected to at least the scaffolding.
In an additional aspect, the present disclosure is directed to a wire-in-wire configuration including a guidewire and an embolic filter coupled to the guidewire. The embolic filter can include a first ring located proximate the distal end of the guidewire and a second ring located between the distal end of the guidewire and a proximal end of the guide wire. The filter can further include a filter membrane coupled to the first and second rings, where the filter membrane can be movable between an undeployed configuration and a deployed configuration upon displacement of the first and second rings relative to each other. The filter can also include an actuator wire extending through a central channel provided in the guidewire where the actuator wire is coupled to one of the first ring or the second ring such that activation of the wire results in a corresponding displacement of the first or second ring. The filter can further include a filter chasis or scaffolding comprising at least one strut extending between and coupled to the first ring and the second ring such that the strut bows outward from the guidewire, deploying the filter membrane, as a distance between the first and second ring decreases.
In another aspect, the temporary embolic filter can comprise a wire-in-wire configuration comprising an outer wire having a lumen with an inner wire movably disposed therein. In this aspect, the filter is constructed substantially identically to the filter described above except that the distal-most first collar is located on a portion of the inner wire extending past the distal terminal end of the outer wire and the second collar is located on a distal portion of the outer wire. In operation, causing the inner wire to move proximally relative to the outer wire causes the filter to move from an undeployed configuration to a deployed configuration and vice-versa.
Additional features and advantages of exemplary implementations of the disclosure will be set forth in the description which follows, and in part will be obvious from the description, or may be learned by the practice of such exemplary implementations. The features and advantages of such implementations may be realized and obtained by means of the instruments and combinations particularly pointed out in the appended claims. These and other features will become more fully apparent from the following description and appended claims, or may be learned by the practice of such exemplary implementations as set forth hereinafter.
The accompanying drawings, which are incorporated in and constitute a part of this specification, illustrate aspects and together with the description, serve to explain the principles of the methods and systems.
The present invention can be understood more readily by reference to the following detailed description, examples, drawing, and claims, and their previous and following description. However, before the present devices, systems, and/or methods are disclosed and described, it is to be understood that this invention is not limited to the specific devices, systems, and/or methods disclosed unless otherwise specified, as such can, of course, vary. It is also to be understood that the terminology used herein is for the purpose of describing particular aspects only and is not intended to be limiting.
The following description of the invention provided as an enabling teaching of the invention in its best, currently known aspect. To this end, those skilled in the relevant art will recognize and appreciate that many changes can be made to the various aspects of the invention described herein, while still obtaining the beneficial results described herein. It will also be apparent that some of the desired benefits described herein can be obtained by selecting some of the features described herein without utilizing other features. Accordingly, those who work in the art will recognize that many modifications and adaptations to the present invention are possible and can even be desirable in certain circumstances and are a part described herein. Thus, the following description is provided as illustrative of the principles described herein and not in limitation thereof.
Reference will be made to the drawings to describe various aspects of one or more implementations of the invention. It is to be understood that the drawings are diagrammatic and schematic representations of one or more implementations, and are not limiting of the present disclosure. Moreover, while various drawings are provided at a scale that is considered functional for one or more implementations, the drawings are not necessarily drawn to scale for all contemplated implementations. The drawings thus represent an exemplary scale, but no inference should be drawn from the drawings as to any required scale.
In the following description, numerous specific details are set forth in order to provide a thorough understanding described herein. It will be obvious, however, to one skilled in the art that the present disclosure may be practiced without these specific details. In other instances, well-known aspects of percutaneous transluminal devices and embolic filters have not been described in particular detail in order to avoid unnecessarily obscuring aspects of the disclosed implementations.
As used in the specification and the appended claims, the singular forms “a,” “an” and “the” include plural referents unless the context clearly dictates otherwise. Ranges may be expressed herein as from “about” one particular value, and/or to “about” another particular value. When such a range is expressed, another aspect includes from the one particular value and/or to the other particular value. Similarly, when values are expressed as approximations, by use of the antecedent “about,” it will be understood that the particular value forms another aspect. It will be further understood that the endpoints of each of the ranges are significant both in relation to the other endpoint, and independently of the other endpoint.
“Optional” or “optionally” means that the subsequently described event or circumstance may or may not occur, and that the description includes instances where said event or circumstance occurs and instances where it does not.
Throughout the description and claims of this specification, the word “comprise” and variations of the word, such as “comprising” and “comprises,” means “including but not limited to,” and is not intended to exclude, for example, other additives, components, integers or steps. “Exemplary” means “an example of” and is not intended to convey an indication of a preferred or ideal aspect. “Such as” is not used in a restrictive sense, but for explanatory purposes.
Referring now to the drawings, in which identical numbers indicate identical elements throughout the various views,
An embolic filter 30 can be mounted to the catheter shaft 14 at or proximal to the distal end 18 of the catheter 12. In additional or alternative embodiments, the filter 30 can be oriented to face towards or away from the treatment device. One skilled in the art will also appreciate in light of the present disclosure that the catheter can be configured to be, for example and without limitation, an over-the-wire catheter, a rapid-exchange catheter and the like. It is solely for clarity of disclosure that the present description describes an over-the-wire catheter modality.
Referring now to
Referring to aspects of the present disclosure illustrated in at least
In one aspect, the distal ring 54 can be fixed in place on the catheter shaft 14, and the proximal ring 56 can be slidably mounted to the catheter shaft for axial movement in the proximal and distal directions. In another aspect, the proximal ring 56 can be fixed in place on the catheter shaft 14, and the distal ring 54 can be slidably mounted to the catheter shaft for axial movement in the proximal and distal directions.
In one aspect illustrated in
In another aspect illustrated in
In yet other aspects, the plurality of second strut sections 70 can be replaced with a sinusoidal ring structure 55 as illustrated in
It is contemplated that each strut can further comprise at least one “zone of weakness,” i.e., a zone of the strut that can be configured to be physically weaker than the majority of the strut in order to control the locations at which the struts bend. One skilled in the art will appreciate that the at least one zone of weakness can be formed in any of a number of ways. In one aspect, a notch can be formed in one or both sides of the strut. In another aspect, at least one of the upper surface and lower surface of the strut can be scored. In another aspect, the at least one zone of weakness can be formed of a material that can be structurally weaker than the material comprising the remainder of the strut. In yet other aspects, the at least one zone of weakness can comprise mechanical hinges. In yet other aspects and as shown in
One skilled in the art will appreciate here are a variety of ways in which the filter scaffolding 52 and actuator wire 84 can be arranged to permit the embolic filter 30 to be opened and closed by moving the proximal end 86 of the actuator wire. In a first aspect, the filter scaffolding 52 can be formed in a normally closed or undeployed position. In operation, pulling the proximal end 86 of the actuator wire 84 can cause the proximal ring 56 to slide in a proximal direction to open the filter scaffolding 52. The filter scaffolding can be configured so that releasing the tension on the actuator wire 84 and/or pushing the actuator wire 84 distally can permit the filter scaffolding 52 to collapse to an un-deployed position.
In another aspect of the present disclosure illustrated in
In yet another aspect of the present disclosure illustrated in
The filter scaffolding 252 can be formed in a normally closed position. In operation, pulling on the actuator wire 284 can displace the distal ring 256 in a distal direction and away from the proximal ring 156 to deploy the filter scaffolding 252. The filter scaffolding can be configured so that releasing the force on the actuator wire 284 can permit the filter scaffolding 252 to return to its un-deployed position.
Referring back to
Referring back to
While
In general, a guidewire is constructed from a smaller (diameter) and more rigid material than a catheter. Similar to catheters, guidewires provide torque control, flexibility and the ability to support the passage of another device or system over it. Due to their structure, guidewires generally provide better trackability (ability navigate vasculature) and steerability.
As will be described below, because a guidewire has a smaller outer diameter than a catheter, a greater variety of thrombectomy tools and treatment devices and be provided over the guidewire to access the treatment position. The tool/treatment device may be movable over the guidewire in multiple directions over guidewire, i.e., axially along the guidewire toward/away from the distal end of the guidewire, rotationally around the diameter of the guidewire. The thrombectomy tool/treatment device can include an angioplasty balloon, a mechanical thrombosis device, an ablation device, or any other tool or surgical device known in the art for treatment of thrombosis.
The increased sized (diameter) of the catheter can increase the possibility of ostial trauma and vascular complications. For vascular treatment, catheter diameters generally range from 4 F to 25 F (outer diameter ranging from 0.055 inches to 0.345 inches), selection depending various factors including the age of the patient and the size of the vessels. In contrast, for vascular treatment, guidewire diameters generally range from 0.010 inches to 0.060 inches. Typically, a physician will choose the smallest diameter catheter feasible to minimize the risk of trauma or complications during the procedure. In contrast, because guidewires have a much smaller diameter than catheters, the diameter of the guidewire is a less significant factor in selection. Instead, selection is guided by vessel anatomy, devices to be used/passed over the guidewire, and physician preference. In the present system, it is contemplated that the guidewire can have an outer diameter between 0.010 inches to 0.060 inches. In another example, the outer diameter can vary between 0.012 inches and 0.045 inches. In yet another example, the outer diameter can vary between 0.014 inches and 0.035 inches.
A catheter is generally described as a hollow flexible tube that is inserted into the body, duct or vessel over a guidewire. The flexibility of a catheter typically necessitates the use of a guidewire. In the present example, because the embolic filter is integral with the guidewire, the system does not require an additional guidewire or other guiding device to direct movement and location of the filter. The flexibility/stiffness of a catheter or a guidewire defines the characteristics of the wire a measure of its elastic modulus and can be measured in terms of its flexural modulus. Flexibility/stiffness varies, for example, in relation to the material properties, core diameter, and physical structure of the catheter/guidewire. The stiffness of a catheter used in vascular treatment ranges from 3.0 g to 50.0 g. In contrast, stiffness of a guidewire used in vascular treatment can range from 1.5 g to 14.0 g. For example, polymer-covered (hydrophilic) wires such as an Abbott HT Pilot® 50 guidewire can have a stiffness of 1.5 g. An Abbott HT Pilot® 150 and 200 can have a stiffness of 2.7 g and 4.1 g, respectively. An Abbott HT Progress® 40, 80, 120 can have a stiffness of 4.8 g, 9.7 g, 13.9 g, respectively. A Boston Scientific Choice PT® can have a stiffness of 1.9 g. Non-covered (non-lubricious) coil guide wires, such as Abbott HT Cross-IT® 100XT can have a stiffness of 1.7 g. An Abbott Miraclebros® can have various stiffness, including, 3.9 g, 4.4 g, 8.8 g, and 13.0 g. A Confianza Pro® can have a stiffness of 9.3 g and 12.4 g. And a Medtronic Persuader® 3, 6 can have a stiffness of 5.1 and 8.0, respectively. Similarly, the flexural modulus of a guidewire used in vascular treatment can range from 9.5 Gpa to 158.4 Gpa. For example, a plain Amplatz type wire has a stiffness of 9.5 GPa. A “heavy duty” Amplantz type wire has a stiffness ranging from 11.4 GPA to 14.5 GPa. A “stiff” Amplantz type wire has a stiffness of 17 GPa. An “extra stiff” Amplantz type wire has a stiffness of 29.2 GPa. A “super stiff” Amplantz type wire has a stiffness of 60.3 GPa. An “ultra stiff” Amplantz type wire has a stiffness of 65.4 GPa. A Backup Meier® wire has a stiffness of 139.6 GPa. A Lunderquist® “extra stiff” wire has a stiffness of 158.4 GPa.
In another aspect illustrated in
In another aspect it may be desirable for the embolic filter and corresponding catheter/guidewire to remain in the patient for an extended period of time, e.g., more than just temporary placement/treatment. Accordingly a catheter/guidewire may be provided with an outer sleeve that permits longer term placement within the patient.
The guidewire with integral embolic filter 300 can include similar components and structure to those described above with respect to the catheters/guidewires illustrated in
As outlined above, the embolic filter 330 comprises a filter membrane 350 and a filter chassis or scaffolding 352, for supporting the membrane. The chassis/scaffolding 352 can include a proximal ring 356 and a distal ring 354. In operation, movement of the proximal ring 356 toward and away from the distal ring 354 cause the embolic filter 330 to open and close. Either the distal ring 354 or the proximal ring 356 can be fixed to the guidewire shaft 314, with the other ring sildably mounted to the guidewire shaft 314 for axial movement in the proximal and distal directions. As provided above, the chassis/scaffolding 352 can include a plurality of rips or struts (and/or a plurality of strut sections) spaced circumferentially around the guidewire 312 and coupled to the proximal and distal rings 356,354. Each strut can further comprise a “zone of weakness” to control the locations at which the struts bend. The plurality of strut section can also be replaced with a sinusoidal ring structure as illustrated in
In operation, movement of the proximal ring 56/distal ring 354 toward and away from each other can be accomplished by manipulation of an actuator wire 384. The guidewire 312 can include an actuator wire lumen 336 that extends from the proximal end 316 to a location proximate the distal end 318 of the guidewire 312. The actuator wire lumen 336 can extend from a proximal port 344 at the proximal end 316 of the guidewire 312, through the guidewire shaft 314, to a distal port 346. The actuator wire 384 can be accessed at the distal port 346 such that the wire can be moved in the proximal and distal directions. As illustrated in
As illustrated in
As illustrated in
As illustrated in
As outlined above, it is contemplated that various thrombectomy tools/treatment devices can be movable (in multiple directions) over the guidewire 312. Likewise, because the combined outer sleeve 390 and guidewire 312 has an outer diameter smaller than a catheter, it is contemplated that various thrombectomy tools/treatment devices can be provided over the combined sleeve 390/guidewire 312.
In yet another aspect, the temporary embolic filter can have a braided nitinol scaffold and, in a further aspect, the scaffold can be configured with a baseline memory in the undeployed configuration. The scaffold can be coupled to a membrane comprising a finely-brained nitinol wire and, in a further aspect, the membrane can be coupled to the inner surface of the scaffold. In a further aspect, the membrane can have a baseline memory in the deployed configuration. In operation, when the scaffold is activated and deployed by the operator, the filter membrane will urge towards its baseline, deployed configuration but will be controllably constrained by the scaffold.
In those aspects in which the force applied to the actuator wire is configured to be an axial compressive force, those skilled in the art can appreciate that a stiffer wire can be used to prevent buckling of the actuator wire than in those embodiments where the force applied to the actuator wire is configured to be an axial tensile force.
In the present disclosure, and especially in the case of actuator wires, the term “wire” is intended to comprise, for example and without limitation, metallic wires, polymeric wires, and the like. In the case of polymeric wires, the polymers used can comprise, for example and without limitation, nylon, polypropylene and the like.
In the foregoing aspects, the filter chassis or scaffold can be formed from any material known to be suitable, including shape-memory materials such as, for example and without limitation, nitinol. It is also contemplated that the scaffold components can be laser cut, formed from braided elements or any other method known in the art.
In the foregoing aspects, the filter membrane 50 can be formed from at least one of a textile, a polymer and a wire mesh or braid. In one non-limiting aspect, the filter membrane can be formed from braided nitinol wire and, in a further aspect, can have a baseline shape corresponding to either a deployed or undeployed configuration. In another aspect, the filter membrane 50 comprises pores and, in a further aspect, the pores can be sized to allow blood to pass but not embolic particles. It is also contemplated that the filter membrane 50 can be mounted either on top of or inside of the frame. It is contemplated that the filter membrane 50 and chassis/scaffolding can have a deployed diameter up to 50 mm or approximately 2 inches.
In the foregoing aspects, the filter membrane 50 can be configured to cover the exterior surface of the outermost strut sections, i.e., the first strut sections 60, 160, and 260. Optionally, the filter membrane 50 can be further configured to extend beyond the distal or second ends 64, 164, and 264, 364 of the first strut sections 60, 160, and 260, where it can be attached to the circumference of the distal ring 54, 154, 254. In those aspects in which the distal ring can be fixed, the filter membrane 50 can optionally be configured to extend beyond the distal end of the distal ring and can be attached to the circumference of the catheter/guidewire shaft 14, 114, 314 at a location between the distal ring 54, 154, 254 and the distal end of the catheter/guidewire shaft.
It is also contemplated that the filter membrane 50 in each of the disclosed embodiments can be attached to the inner surfaces of the first strut sections 60, 160, and 260 instead of to the outer surfaces.
It is further contemplated that the inner or second strut sections 70, 170, 270 can also be configured in a concave shape with respect to the blood flow when the filter scaffolding is deployed. In further or additional aspects, the filter membrane 50 can be attached to the inner or outer surfaces of the second strut sections 70, 170, 270. When the filter membrane 50 is attached to the surfaces of the second strut sections 70, 170, 270, the filter membrane 50 can optionally extend beyond the distal or second ends 74, 174, 274 of the second strut sections and be attached to the circumference of the proximal ring 56, 156, 256, 356. It is also contemplated that, if the filter membrane 50 can be attached to the outer surfaces of the second strut sections 70 and the proximal ring 56, 156, 256, 356 can be fixed, the filter membrane can be configured to extend beyond the distal end of the proximal ring and can be attached to the catheter shaft 14 at a location between the proximal and distal rings 56, 54.
In all of the foregoing instances, the filter scaffolding comprises a fixed ring and a movable ring, raising the filter can be accomplished by moving the rings apart, and collapsing the filter can be achieved by moving the rings together or vice-versa. “Moving apart” and “moving together” are used as relative terms, such that only one of the two rings need move with respect to the other ring for the rings to “move apart” or “move together.”
Similarly, the process of raising and collapsing the filter can be thought of as being viewed from the perspective of the catheter, such that a movable ring can be moved toward or away from a fixed ring.
In all of the foregoing instances, one can appreciate that both actively applying a force to move a ring and releasing a force to permit the ring to move of its own accord comprise a step of “causing” the movable ring to move by “controlling” the actuator wire. Thus, in both the normally deployed and normally un-deployed filter scaffolding embodiments described herein, the actuator wire can be “controlled” to “cause” a movable ring to move, whether that control takes the form of applying or releasing a force on the actuator wire.
It is also contemplated that, rather than having the physician directly grasp the proximal end of the actuator wire, a control device can be associated with the proximal end of the actuator wire at the proximal end of the catheter shaft. The control device can incorporate, for example and without limitation, levers, sliders, rotating spindles, or the like to facilitate movement of the wire. One example of such a mechanical arrangement is described in U.S. Patent Publication No. US 2010/0106182, paragraphs [0079]-[0090] and FIGS. 29-33, which disclosure is hereby incorporated by reference.
Use of the temporary embolic filter described above to prevent an embolism in a blood vessel can be shown in
In
In
In
One implementation of each of the disclosed embolic filters can be adjunct to treatment of an ilio-femoral DVT. Here, prior to insertion of the thrombectomy device, the temporary embolic filter would be inserted into and deployed in the inferior vena cava and used as described above. In another implementation, the disclosed embolic filters can be used in the subclavian vein and axillary vein while treating patients with arterio-venous (a-v) access thrombosis. In other implementations, it is contemplated that the disclosed embolic filters can be used in any vascular bed.
The present invention can thus be embodied in other specific forms without departing from its spirit or essential characteristics. The described aspects are to be considered in all respects only as illustrative and not restrictive. The scope of the invention is, therefore, indicated by the appended claims rather than by the foregoing description. All changes that come within the meaning and range of equivalency of the claims are to be embraced within their scope.
The present disclosure claims priority to U.S. Patent Application No. 62/005,226, filed Sep. 25, 2014, entitled “Temporary Embolic Protection Device and Methods Thereof,” which is incorporated herein by reference in its entirety.
Number | Date | Country | |
---|---|---|---|
62055226 | Sep 2014 | US |